Skip to content

Clinical trials

Completed Atherosclerosis trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Switzerland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20073
20112
20122
20131
20141
20165
20183
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern3
University of Zurich2
Abbott Medical Devices1
Amgen1
AstraZeneca1
Bayer1
Biotronik AG1
Boston Scientific Corporation1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis22
Coronary Artery Disease7
Cardiovascular Diseases6
Peripheral Arterial Disease5
Heart Failure3
Acute Coronary Syndrome2
Dyslipidemias2
Myocardial Infarction2
Acquired Immunodeficiency Syndrome1
Arterial Occlusive Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.